A stability indicating assay method for cefuroxime axetil and its application to analysis of tablets exposed to accelerated stability test conditions

Journal of Chromatography A

Volumn 1119, Issue 1-2, 2006, Pages 209-215

  Ivana, Ivanovic ^a   Ljiljana, Zivanovic ^b   Mira, Zecevic ^b  

^a Department of Separation Technology   (Serbia)

^b Faculty of Pharmacy   (Serbia)

Author keywords

Cefuroxime axetil; Degradation products; Geometrical and positional isomers; RP HPLC; Stability testing

Indexed keywords

ATMOSPHERIC HUMIDITY; DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERS;

CEFUROXIME AXETIL; DEGRADATION PRODUCTS; GEOMETRICAL AND POSITIONAL ISOMERS; REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (RP-HPLC); STABILITY TESTING;

ANTIBIOTICS;

CEFOXIM; CEFUROXIME AXETIL;

ARTICLE; DEGRADATION; HUMIDITY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; TABLET; VALIDATION PROCESS;

EID: 33744814334     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2005.12.079     Document Type: Article

References (44)

1. Ahuja S. Impurities Evaluation of Pharmaceuticals (1998), Marcel Dekker, Inc., New York, USA
2. Ahuja S., and Alsante K.M. Handbook of Isolation and Characterisation of Impurities in Pharmaceuticals (2003), Academic Press, San Diego, USA
3. FDA, Guidance for Industry: Impurities in Drug Product, Draft guidance, Center for Drug Evaluation and Research (CDER), 1998.
4. FDA, Draft Guidance for Industry: Stability Testing of Drug Substances and Drug Products, FDA, Rockville, MD, 1998.
5. International Conference on Harmonisation (ICH), Guidance for Industry, Q1A(R2): Stability Testing of New Drug Substances and Products, IFPMA, Geneva, 2000.
6. Grimm W. In: Carstensen J.T., and Rhodes C.T. (Eds). Drug Stability, Principles and Practices (2000), Marcel Decer, Inc., New York
7. Dean D.A. In: Carstensen J.T., and Rhodes C.T. (Eds). Drug Stability, Principles and Practices (2000), Marcel Decer, Inc., New York
8. ICH Harmonised Tripartite Guedline, Q1F: Stability Data Package For Registration Applications in Climatic Zones III and IV, London, 2003.
9. Williams D.A., and Lemke T.L. Foye's Principles of Medicinal Chemistry (2002), Lippincott Williams & Wilkins, Baltimore, USA
10. Wilson and Gisvold's, Textbook of Organic Medicinal and Pharmaceutical Chemistry, Lippincott-Raven, Philadelphia, 1998.
11. AHFS DRUGS INFORMATION, American Society of Helth-System Pharmacists, Inc., Bethesda, USA, 2003.
12. Snyder N.J., Tabas L.B., Berry D.M., Duckworth D.C., Spry D.O., and Dantzig A.H. Antimicrob. Agents Chemother. 41 (1997) 1649
13. Popa E., Huang M.J., Brewstera M.E., and Bodora N. J. Mol. Struct. 315 (1994) 1
14. Pop E., Brewster M.E., Dinculescu A., Huang M.J., and Bodor N. Heterocycles 37 (1994) 477
15. Stoeckel K., Hofheinz W., Laneury J.P., Duchene P., Shedlofsky S., and Blouin R. Antimicrob. Agents Chemother. 42 (1998) 2602
16. Miyauchi M., Sasahara K., Fujimoto K., Kawamoto I., and Ide J. Chem. Pharm. Bull. 37 (1989) 3272
17. Richter W.F., Chong Y.H., and Stella V.J. J. Pharm. Sci. 79 (1990) 185
18. Vilanova B., Frau J., Llinas A., Coll M., Munoz F., and Donoso J. Electronic Conference on Heterocyclic Chemistry (1996) ECHET96
19. European Pharmacopoeia, 4th ed., Council of Europe, Strasburg, Cedex 2002.
20. USP 27, United States Pharmacopoeial Convencion, Inc., Washington, DC, 2004.
21. Walily E., Fattah M.A., Gazy A.A.K., Saied F.B., Khamis, and Essam F. Spectrosc. Lett. 33 (2000) 931
22. Murillo J.A., Lemus J.M., and Garcia L.F. J. Pharm. Biomed. Anal. 12 (1994) 875
23. Ayad M.M., Shalaby A.A., Abdellatef H.E., and Elsaid H.M. J. Pharm. Biomed. Anal. 18 (1999) 975
24. Al-Momani I.F. J. Pharma. Biomed. Anal. 25 (2001) 751
25. Krzek J., and Dabrowska-Tylka M. Chromatographia 58 (2003) 231
26. Sung K.C., Changchein Y.C., Chuangchen P., Lu C.L., Han R.Y., and Lin Y.Y. J. Food Drug Anal. 7 (1999) 45
27. Rosseel M.T., Peleman R., Van Hoorebeke H., and Pauwels R.A. J. Chromatogr. B 689 (1997) 438
28. Tsai T.H., Cheng F.C., Chen K.C., Chen Y.F., and Chen C.F. J. Chromatogr. B 735 (1999) 25
29. Ruiz-Carretero P., Nacher A., Merino-Sanjuan M., and Casabo V.G. Int. J. Pharm. 202 (2000) 89
30. Moats W.A., and Romanowski R.D. J. Chromatogr. A 812 (1998) 237
31. Barrett M.A., Lawrence M.J., Jackson H.C., Hatt A.J., and Lansley A.B. Eur. J. Pharm. Sci. 4 (1996) S195
32. Pajchel G., and Tyski S. J. Chromatogr. A 895 (2000) 27
33. Mrestani Y., Neubert R., and Schiewe J. J. Chromatogr. B 1-2 (1997) 321
34. Mrestani Y., Neubert R.H.H., Hartl A., and Wohlrab J. Anal. Chim. Acta 349 (1997) 207
35. Zajac M., Jelinska A., Dobrowolski L., and Oszczapowicz I. J. Pharm. Biomed. Anal. 32 (2003) 1181
36. Zegota H., Koprowski M., and Zegota A. Radiat. Phys. Chem. 43 (1994) 343
37. Galanti L.M., Hecq J.D., Vanbeckbergen D., and Jamart J. J. Clin. Pharm. Ther. 21 (1996) 185
38. Faouzi M.A., Dine T., Luyckx M., Gressier B., and Brunet C. Die Pharmazie 49 (1994) 425
39. Barnes A.R. J. Clin. Pharm. Ther. 15 (1990) 187
40. Fabre H., Ibork H., and Lerner D.A. J. Pharm. Sci. 83 (1994) 553
41. International Conference on Harmonisation, Topic Q2B, Validation of Analyical Methods: Methodology, The European Agency for the Evaluation of Medicinal Products, Yokohama, Japan, 1996.
42. Hong D.D., and Shah M. In: Carstensen J.T., and Rhodes C.T. (Eds). Drug Stability, Principles and Practices (2000), Marcel Dekker, Inc., New York
43. Bakshi M., and Singh S. J. Pharm. Biomed. Anal. 28 (2002) 1011
44. FDA, Guidance for Industry: Analytical Procedures and Methods Validation, Center for Drug Evaluation and Research (CDER), 2000.